Sharps Compliance (SMED) 10-Q 3 Feb 21 2021 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Dec. 31, 2020	Feb. 01, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Dec. 31, 2020
Document Transition Report	false
Entity File Number	001-34269
Entity Registrant Name	SHARPS COMPLIANCE CORP
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	74-2657168
Entity Address, Address Line One	9220 Kirby Drive
Entity Address, Address Line Two	Suite 500
Entity Address, City or Town	Houston
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	77054
City Area Code	713
Local Phone Number	432-0300
Title of 12(b) Security	Common Shares, $0.01 Par Value
Trading Symbol	SMED
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		16,511,602
Entity Central Index Key	0000898770
Current Fiscal Year End Date	--06-30
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q2
Amendment Flag	false

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Dec. 31, 2020	Jun. 30, 2020
CURRENT ASSETS
Cash	$ 7,226	$ 5,416
Accounts receivable, net	13,286	11,789
Inventory	5,296	5,638
Contract asset	32	156
Prepaid and other current assets	793	1,287
TOTAL CURRENT ASSETS	26,633	24,286
PROPERTY, PLANT AND EQUIPMENT, net	10,270	9,127
OPERATING LEASE RIGHT OF USE ASSET	9,238	8,747
INVENTORY, net of current portion	1,027	1,064
OTHER ASSETS	160	154
GOODWILL	6,735	6,735
INTANGIBLE ASSETS, net	2,526	2,771
DEFERRED TAX ASSET	1,008	1,252
TOTAL ASSETS	57,597	54,136
CURRENT LIABILITIES
Accounts payable	3,129	3,291
Accrued liabilities	2,879	2,833
Operating lease liability	2,471	2,192
Current maturities of long-term debt	2,252	1,658
Contract liability	3,939	3,262
TOTAL CURRENT LIABILITIES	14,670	13,236
CONTRACT LIABILITY, net of current portion	954	705
OPERATING LEASE LIABILITY, net of current portion	6,939	6,671
OTHER LIABILITIES	383	441
LONG-TERM DEBT, net of current portion	3,525	3,505
TOTAL LIABILITIES	26,471	24,558
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY
Common stock, $0.01 par value per share; 40,000,000 shares authorized; 16,799,702 and 16,667,572 shares issued, respectively and 16,504,087 and 16,371,957 shares outstanding, respectively	170	168
Treasury stock, at cost, 295,615 shares repurchased	(1,554)	(1,554)
Additional paid-in capital	30,814	30,203
Retained earnings	1,696	761
TOTAL STOCKHOLDERS' EQUITY	31,126	29,578
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 57,597	$ 54,136

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares	Dec. 31, 2020	Jun. 30, 2020
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	40,000,000	40,000,000
Common stock, shares issued (in shares)	16,799,702	16,667,572
Common stock, shares outstanding (in shares)	16,504,087	16,371,957
Treasury stock, shares repurchased (in shares)	295,615	295,615

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Income Statement [Abstract]
REVENUES	$ 17,011	$ 14,565	$ 30,162	$ 28,164
Cost of revenues	11,374	9,693	20,902	18,808
GROSS PROFIT	5,637	4,872	9,260	9,356
Selling, general and administrative	3,756	3,606	7,544	7,118
Depreciation and amortization	205	197	409	401
OPERATING INCOME	1,676	1,069	1,307	1,837
OTHER INCOME (EXPENSE)
Interest income	0	4	0	9
Interest expense	(47)	(26)	(79)	(45)
Income associated with derivative instrument	10	0	15	0
TOTAL OTHER EXPENSE	(37)	(22)	(64)	(36)
INCOME BEFORE INCOME TAXES	1,639	1,047	1,243	1,801
INCOME TAX EXPENSE
Current	64	33	64	56
Deferred	347	44	244	89
TOTAL INCOME TAX EXPENSE	411	77	308	145
NET INCOME	$ 1,228	$ 970	$ 935	$ 1,656
NET INCOME (LOSS) PER COMMON SHARE - Basic and Diluted (in dollars per share)	$ 0.07	$ 0.06	$ 0.06	$ 0.10
WEIGHTED AVERAGE SHARES USED IN COMPUTING NET INCOME PER COMMON SHARE:
Basic (in shares)	16,497	16,225	16,444	16,185
Diluted (in shares)	16,929	16,303	16,875	16,236

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-in Capital	Retained Earnings
Balance at beginning (in shares) at Jun. 30, 2019		16,433,128,000	(295,615,000)
Balances at beginning at Jun. 30, 2019	$ 26,126	$ 165	$ (1,554)	$ 29,020	$ (1,505)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	19,350	19,350,000
Exercise of stock options	$ 58			58
Stock-based compensation	225			225
Issuance of restricted stock (in shares)		72,000,000
Issuance of restricted stock	0	$ 1		(1)
Net income	1,656				1,656
Balance at end (in shares) at Dec. 31, 2019		16,524,478,000	(295,615,000)
Balances at end at Dec. 31, 2019	28,065	$ 166	$ (1,554)	29,302	151
Balance at beginning (in shares) at Sep. 30, 2019		16,442,328,000	(295,615,000)
Balances at beginning at Sep. 30, 2019	$ 26,944	$ 165	$ (1,554)	29,152	(819)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	10,150	10,150,000
Exercise of stock options	$ 30			30
Stock-based compensation	121			121
Issuance of restricted stock (in shares)		72,000,000
Issuance of restricted stock	0	$ 1		(1)
Net income	970				970
Balance at end (in shares) at Dec. 31, 2019		16,524,478,000	(295,615,000)
Balances at end at Dec. 31, 2019	28,065	$ 166	$ (1,554)	29,302	151
Balance at beginning (in shares) at Jun. 30, 2020		16,667,572,000	(295,615,000)
Balances at beginning at Jun. 30, 2020	$ 29,578	$ 168	$ (1,554)	30,203	761
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	68,531,000	68,531,000
Exercise of stock options	$ 311	$ 1		310
Stock-based compensation	302			302
Issuance of restricted stock (in shares)		63,599,000
Issuance of restricted stock	0	$ 1		(1)
Net income	935				935
Balance at end (in shares) at Dec. 31, 2020		16,799,702,000	(295,615,000)
Balances at end at Dec. 31, 2020	31,126	$ 170	$ (1,554)	30,814	1,696
Balance at beginning (in shares) at Sep. 30, 2020		16,718,103,000	(295,615,000)
Balances at beginning at Sep. 30, 2020	$ 29,672	$ 169	$ (1,554)	30,589	468
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	18,000,000	18,000,000
Exercise of stock options	$ 86			86
Stock-based compensation	140			140
Issuance of restricted stock (in shares)		63,599,000
Issuance of restricted stock	0	$ 1		(1)
Net income	1,228				1,228
Balance at end (in shares) at Dec. 31, 2020		16,799,702,000	(295,615,000)
Balances at end at Dec. 31, 2020	$ 31,126	$ 170	$ (1,554)	$ 30,814	$ 1,696

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$ 935	$ 1,656
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	923	803
Bad debt expense	100	49
Inventory write-off	24	13
Loss on disposal of property, plant and equipment	1	0
Stock-based compensation expense	302	225
Income on derivative instrument	(15)	0
Deferred tax expense	244	89
Changes in operating assets and liabilities:
Accounts receivable	(1,597)	(3,067)
Inventory	355	640
Prepaid and other assets	488	(213)
Accounts payable and accrued liabilities	160	614
Contract asset and contract liability	1,050	960
NET CASH PROVIDED BY OPERATING ACTIVITIES	2,970	1,769
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment	(2,023)	(1,236)
Additions to intangible assets	(62)	(65)
NET CASH USED IN INVESTING ACTIVITIES	(2,085)	(1,301)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from exercise of stock options	311	58
Proceeds from long-term debt	961	598
Repayments of long-term debt	(347)	(258)
Payments of debt issuance costs	0	(50)
NET CASH PROVIDED BY FINANCING ACTIVITIES	925	348
NET INCREASE IN CASH	1,810	816
CASH, beginning of period	5,416	4,512
CASH, end of period	7,226	5,328
SUPPLEMENTAL CASH FLOW DISCLOSURES:
Income taxes paid, net of refunds	(261)	62
Interest paid on long-term debt	80	42
NON-CASH INVESTING ACTIVITIES:
Property, plant and equipment financed through accounts payable	$ (263)	$ (18)

ORGANIZATION AND BACKGROUND

ORGANIZATION AND BACKGROUND	6 Months Ended
	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND BACKGROUND	ORGANIZATION AND BACKGROUND Organization : The accompanying unaudited condensed consolidated financial statements include the financial transactions and accounts of Sharps Compliance Corp. and its wholly owned subsidiaries, Sharps Compliance, Inc. of Texas (dba Sharps Compliance, Inc.), Sharps e-Tools.com Inc. (“Sharps e-Tools”), Sharps Manufacturing, Inc., Sharps Environmental Services, Inc. (dba Sharps Environmental Services of Texas, Inc.), Sharps Safety, Inc., Alpha Bio/Med Services LLC, Bio-Team Mobile LLC, Citiwaste, LLC and Sharps Properties, LLC (collectively, “Sharps” or the “Company”). All significant intercompany accounts and transactions have been eliminated upon consolidation. Business : Sharps is a full-service national provider of comprehensive waste management services including medical, pharmaceutical and hazardous for small and medium quantity generators. The Company’s solutions include Sharps Recovery System™ (formerly Sharps Disposal by Mail System ® ), TakeAway Recovery System, TakeAway Medication Recovery System™, MedSafe ® , TakeAway Recycle System™, ComplianceTRAC SM , SharpsTracer ® , Sharps Secure ® Needle Disposal System, Complete Needle™ Collection & Disposal System, TakeAway Environmental Return System™, Pitch-It IV™ Poles, Asset Return System and Spill Kit Recovery System . The Company also offers its route-based pick-up services in a thirty-two (32) state region of the South, Southeast, Midwest and Northeast portions of the United States.

BASIS OF PRESENTATION

BASIS OF PRESENTATION	6 Months Ended
	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION	BASIS OF PRESENTATION The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial information and with instructions to Form 10-Q and, accordingly, do not include all information and footnotes required under generally accepted accounting principles in the United States of America ("GAAP") for complete financial statements. Additionally, the preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect reported amounts. In the opinion of management, these interim condensed consolidated financial statements contain all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation of the consolidated financial position of the Company as of December 31, 2020, the results of its operations for the three and six months ended December 31, 2020 and 2019, cash flows for the six months ended December 31, 2020 and 2019, and stockholders’ equity for the three and six months ended December 31, 2020 and 2019. The results of operations for the three and six months ended December 31, 2020 are not necessarily indicative of the results to be expected for the entire fiscal year ending June 30, 2021. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended June 30, 2020. A novel strain of coronavirus ("COVID-19") was first identified in December 2019, and subsequently declared a global pandemic by the World Health Organization on March 11, 2020. As a result of the outbreak, many companies have experienced disruptions in their operations and in servicing customers. The Company has implemented some and may take additional precautionary measures intended to help ensure the well-being of its employees, facilitate continued uninterrupted servicing of customers and minimize business disruptions. The full extent of the future impacts of COVID-19 on the Company's operations is uncertain. A prolonged outbreak could have a material adverse impact on the financial results and business operations of the Company. To date, the Company has not identified any material adverse impact of COVID-19 on its financial position and results of operations.

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	SIGNIFICANT ACCOUNTING POLICIES Revenue Recognition: The components of revenues by solution which reflect a disaggregation of revenue by contract type are as follows (dollar amounts in thousands): Three-Months Ended December 31, 2020 % Total 2019 % Total REVENUES BY SOLUTION: Mailbacks $ 10,452 61.4 % $ 8,564 58.8 % Route-based pickup services 3,491 20.5 % 2,480 17.0 % Unused medications 1,713 10.1 % 2,321 15.9 % Third party treatment services 179 1.1 % 66 0.5 % Other (1) 1,176 6.9 % 1,134 7.8 % Total revenues $ 17,011 100.0 % $ 14,565 100.0 % Six-Months Ended December 31, 2020 % Total 2019 % Total REVENUES BY SOLUTION: Mailbacks $ 16,614 55.2 % $ 15,681 55.7 % Route-based pickup services 6,647 22.0 % 5,137 18.2 % Unused medications 4,074 13.5 % 4,704 16.7 % Third party treatment services 314 1.0 % 85 0.3 % Other (1) 2,513 8.3 % 2,557 9.1 % Total revenues $ 30,162 100.0 % $ 28,164 100.0 % (1) The Company’s other products include IV poles, accessories, containers, asset return boxes and other miscellaneous items with single performance obligations. Vendor Managed Inventory ("VMI") - The VMI program includes terms that meet the “bill and hold” criteria and as such are recognized when the order is placed, title has transferred, there are no acceptance provisions and amounts are segregated in the Company’s warehouse for the customer. During the three and six months ended December 31, 2020, the Company recorded billings from inventory builds that are held in VMI under these service agreements of $2.5 million and $3.5 million, respectively. During the three and six months ended December 31, 2019, the Company recorded billings from inventory builds that are held in VMI under these service agreements of $1.9 million and $2.4 million, respectively. As of December 31, 2020 and June 30, 2020, $4.6 million and $2.8 million , respectively, of solutions sold through that date were held in vendor managed inventory pending fulfillment or shipment to patients of pharmaceutical manufacturers who offer these solutions to patients in an ongoing patient support program. The contract asset is related to VMI service agreements within the maibacks contract type category when the revenue recognition exceeds the amount of consideration the Company was entitled to at the point in time of satisfying the performance obligation associated with the sale of the compliance and container system. The contract liability is related to the mailbacks and unused medications contract type categories in which cash consideration exceeds the transaction price allocated to completed performance obligations. The amount recognized during the six months ended December 31, 2020 related to contract liabilities recorded as of June 30, 2020 was $2.1 million. Income Taxes : Deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is established when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The establishment of valuation allowances requires significant judgment and is impacted by various estimates. Both positive and negative evidence, as well as the objectivity and verifiability of that evidence, is considered in determining the appropriateness of recording a valuation allowance on deferred tax assets. The Company has historically recorded a valuation allowance to reduce its deferred tax assets to an amount that is more likely than not to be realized. However, during the year ended June 30, 2020, the Company released the full amount of the valuation allowance against its deferred tax assets on the basis of the Company's reassessment of the recoverability of its deferred tax assets. Accounts Receivable : Accounts receivable consist primarily of amounts due to the Company from normal business activities. Accounts receivable balances are determined to be delinquent when the amount is past due based on the contractual terms with the customer. The Company maintains an allowance for doubtful accounts to reflect the likelihood of not collecting certain accounts receivable based on past collection history and specific risks identified among uncollected accounts. Accounts receivable are charged to the allowance for doubtful accounts when the Company determines that the receivable will not be collected and/or when the account has been referred to a third party collection agency. The Company has a history of minimal uncollectible accounts. Goodwill and Other Identifiable Intangible Assets: Finite-lived intangible assets are amortized over their respective estimated useful lives and evaluated for impairment periodically whenever events or changes in circumstances indicate that their related carrying values may not be fully recoverable. Goodwill is assessed for impairment at least annually. The Company generally performs its annual goodwill impairment analysis using a quantitative approach. The quantitative goodwill impairment test identifies the existence of potential impairment by comparing the fair value of its single reporting unit with its carrying value, including goodwill. If the fair value of a reporting unit exceeds its carrying value, the reporting unit's goodwill is considered not to be impaired. If the carrying value of a reporting unit exceeds its fair value, an impairment charge is recognized in an amount equal to that excess. The impairment charge recognized is limited to the amount of goodwill present in the single reporting unit. These estimates and assumptions could have a significant impact on whether or not an impairment charge is recognized and the amount of any such charge. The Company performs its annual impairment assessment of goodwill during the fourth quarter of each fiscal year. The Company determined that there was no impairment during the prior year ended June 30, 2020 and there have been no triggering events since that date that would warrant further impairment testing.

RECENTLY ISSUED ACCOUNTING STAN

RECENTLY ISSUED ACCOUNTING STANDARDS	6 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
RECENTLY ISSUED ACCOUNTING STANDARDS	RECENTLY ISSUED ACCOUNTING STANDARDS In March 2020, guidance for applying optional expedients and exceptions to ease the potential burden in accounting for reference rate reform on financial reporting was issued. It is elective and applies to all entities, subject to meeting certain criteria, that have contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform on financial reporting. The provisions of the new guidance are effective for interim periods beginning as of March 12, 2020 through December 31, 2022. There has been no material impact on the Company's consolidated financial statements and related disclosures from the modification of its arrangements as of December 31, 2020. The Company will continue to evaluate the standard as well as additional changes, modifications or interpretations which may impact the Company. In June 2016, guidance for credit losses of financial instruments was issued, which requires entities to measure credit losses for financial assets measured at amortized cost based on expected losses rather than incurred losses. The provisions of the new guidance are effective for annual periods beginning after December 15, 2022 (effective July 1, 2023 for the Company), including interim periods within the reporting period, and early application is permitted. The Company is in the initial stages of evaluating the impact of the new guidance on its consolidated financial statements and related disclosures as well as evaluating the available transition methods. The Company will continue to evaluate the standard as well as additional changes, modifications or interpretations which may impact the Company.

INCOME TAXES

INCOME TAXES	6 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXESThe Company’s effective tax rate for the six months ended December 31, 2020 and 2019 was 24.8% and 8.1%, respectively. During the six months ended December 31, 2020, the effective tax rate is based on the statutory federal tax rate of 21%, now that the valuation has been removed since June 30, 2020, as well as an approximated 5% state income tax rate net of the federal benefit. During the six months ended December 31, 2019, the effective tax rate represented the deferred tax expense related to the effects of indefinite lived intangible assets, such as goodwill, which could not be used as a source of future taxable income in evaluating the need for a valuation allowance against deferred tax assets as well as the effects of the state income tax expense for the period.

LEASES

LEASES	6 Months Ended
	Dec. 31, 2020
Leases [Abstract]
LEASES	LEASES The Company has operating leases for real estate, field equipment, office equipment and vehicles. Operating leases are included in Operating Lease Right of Use ("ROU") Asset and Operating Lease Liability on our Condensed Consolidated Balance Sheets. During the three and six months ended December 31, 2020 and 2019, lease cost amounts, which reflect the fixed rent expense associated with operating leases, are as follows (in thousands): Three-Months Ended December 31, Six-Months Ended December 31, 2020 2019 2020 2019 Lease cost (1) - operating lease cost - fixed rent expense included in: Cost of revenues $ 621 $ 451 $ 1,192 $ 885 Selling, general and administrative 113 79 226 182 Total $ 734 $ 530 $ 1,418 $ 1,067 (1) Finance lease cost, short-term lease cost and variable lease cost were not significant during the period. During the six months ended December 31, 2020 and 2019, the Company had the following cash and non-cash activities associated with leases (in thousands): Six-Months Ended December 31, 2020 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash outflow for operating leases $ 1,357 $ 1,067 Non-cash changes to the Operating ROU Asset and Operating Lease Liability Additions and modifications to ROU asset obtained from new operating lease liabilities $ 1,688 $ 5,126 Additions to ROU asset obtained from operating lease liabilities upon adoption of new guidance $ — $ 4,591 As of December 31, 2020, the weighted average remaining lease term for all operating leases is 4.69 years. The weighted average discount rate associated with operating leases as of December 31, 2020 is 4.4%. The future payments due under operating leases as of December 31, 2020 is as follows (in thousands): Future payments due in the twelve months ended December 31, 2021 $ 2,828 2022 2,156 2023 1,945 2024 1,735 2025 1,095 Thereafter 675 Total undiscounted lease payments 10,434 Less effects of discounting (1,024) Lease liability recognized $ 9,410

NOTES PAYABLE AND LONG-TERM DEB

NOTES PAYABLE AND LONG-TERM DEBT	6 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
NOTES PAYABLE AND LONG-TERM DEBT	NOTES PAYABLE AND LONG-TERM DEBT On March 29, 2017, the Company entered into a credit agreement with a commercial bank which was subsequently amended on June 29, 2018 and on December 28, 2020 (“Credit Agreement”). The amended Credit Agreement, which expires on December 28, 2023, provides for a $14.0 million committed credit facility that can be increased to $18 million upon the Company's request. The proceeds of the Credit Agreement may be utilized as follows: (i) $6.0 million for working capital, letters of credit (up to $2.0 million) and general corporate purposes, (ii) $8.0 million for acquisitions and (iii) an additional $4 million for working capital, upon the Company's request. Indebtedness under the Credit Agreement is secured by substantially all of the Company’s assets with advances outstanding under the working capital portion of the credit facility at any time limited to a Borrowing Base (as defined in the Credit Agreement) equal to 80% of eligible accounts receivable plus the lesser of (i) 50% of eligible inventory and (ii) $3.0 million. Advances under the acquisition portion of the credit facility are limited to 75% of the purchase price of an acquired company and convert to a five One On August 21, 2019, certain subsidiaries of the Company entered into a Construction and Term Loan Agreement and a Master Equipment Finance Agreement with its existing commercial bank (collectively, the “Loan Agreement”). The Loan Agreement provides for a five On April 20, 2020, the Company received loan proceeds of $2.2 million under the Paycheck Protection Program (“PPP”) under a promissory note from its existing commercial bank (the “PPP Loan”). The PPP, established as part of the CARES Act, provides for loans to qualifying businesses for amounts up to 2.5 times the average monthly payroll expenses of the qualifying business. The loans and accrued interest may be forgivable after eight to twenty-four weeks providing that the borrower uses the loan proceeds for eligible purposes, including payroll, benefits, rent and utilities, and maintains its payroll levels. The application for these funds requires the Company to, in good faith, certify that the current economic uncertainty made the loan request necessary to support the ongoing operations of the Company. Some of the uncertainties related to the Company’s operations that are directly related to COVID-19 include, but are not limited to, the severity of the virus, the duration of the outbreak, governmental, business or other actions (which could include limitations on operations or mandates to provide products or services), impacts on the supply chain, and the effect on customer demand or changes to operations. In addition, the health of the Company’s workforce, and its ability to meet staffing needs in its route-based, treatment and distribution operations and other critical functions are uncertain and is vital to its operations. The PPP Loan certification further requires the Company to take into account our current business activity and our ability to access other sources of liquidity sufficient to support ongoing operations in a manner that is not significantly detrimental to the business. While the Company does have availability under its Credit Agreement, $8.0 million of such availability can only be used for acquisitions and the $6.0 million that is available is in place to support working capital needs, along with current cash on hand. Further, the Company has a limited market capitalization and lack of history of being able to access the capital markets and as a result, the Company believes it meets the certification requirements. The receipt of these funds, and the forgiveness of the loan attendant to these funds, is dependent on the Company having initially qualified for the loan and qualifying for the forgiveness of such loan based on our future adherence to the forgiveness criteria. The term of the Company’s PPP Loan is two years . The Company has applied for forgiveness of the PPP Loan via its existing commercial bank under the guidelines provided by the Small Business Administration ("SBA") and the Department of Treasury. The annual interest rate on the PPP Loan is 1.0% and no payments of principal or interest are due during at least the six-month period beginning on the date of the PPP Loan. The PPP Loan is subject to any new guidance and new requirements released by the Department of the Treasury who has indicated that all companies that have received funds in excess of $2.0 million will be subject to a government (SBA) audit to further ensure PPP loans are limited to eligible borrowers in need. At December 31, 2020 and June 30, 2020, long-term debt consisted of the following (in thousands): December 31, 2020 June 30, 2020 Acquisition loan, monthly payments of $43; maturing March 2022 $ 690 $ 948 Equipment loan, monthly payments of $17; maturing August 2024, net of debt issuance costs of $47 928 929 Real estate loan, monthly payments of $5; maturing August 2024 1,976 1,103 Paycheck Protection Program loan 2,183 2,183 Total long-term debt 5,777 5,163 Less: current portion 2,252 1,658 Long-term debt, net of current portion $ 3,525 $ 3,505 The Company has availability under the Credit Agreement of $13.9 million ($5.9 million for the working capital and $8.0 million for acquisitions) as of December 31, 2020 with the option to extend the availability up to $17.9 million. The Company has $0.1 million in letters of credit outstanding as of December 31, 2020. The Credit and Loan Agreements contain affirmative and negative covenants that, among other things, require the Company to maintain a maximum cash flow leverage ratio of no more than 3.0 to 1.0 and a minimum debt service coverage ratio of not less than 1.15 to 1.00. The Credit and Loan Agreements also contain customary events of default which, if uncured, may terminate the agreements and require immediate repayment of all indebtedness to the lenders. The leverage ratio covenant may limit the amount available under the agreements. The Company was in compliance with all the financial covenants under the Credit and Loan Agreements as of December 31, 2020. Payments due on long-term debt subsequent to December 31, 2020 are as follows (in thousands): Twelve Months Ending December 31, 2021 $ 2,252 2022 1,153 2023 272 2024 272 2025 and thereafter 1,875 $ 5,824 On January 22 , 2021, certain wholly owned subsidiaries of the Company entered into a real estate term loan agreement (the "Real Estate Loan Agreement") with its existing commercial bank. The Real Estate Loan Agreement provides for a five

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION	6 Months Ended
	Dec. 31, 2020
Share-based Payment Arrangement [Abstract]
STOCK-BASED COMPENSATION	STOCK-BASED COMPENSATIONStock-based compensation cost for options and restricted stock awarded to employees and directors is measured at the grant date based on the calculated fair value of the award and is recognized as an expense over the requisite service period (generally the vesting period of the equity grant). Total stock-based compensation expense for the three and six months ended December 31, 2020 and 2019 is as follows (in thousands): Three-Months Ended December 31, Six-Months Ended December 31, 2020 2019 2020 2019 Stock-based compensation expense included in: Cost of revenues $ — $ 1 $ — $ 3 Selling, general and administrative 140 120 302 222 Total $ 140 $ 121 $ 302 $ 225

EARNINGS PER SHARE

EARNINGS PER SHARE	6 Months Ended
	Dec. 31, 2020
Earnings Per Share [Abstract]
EARNINGS PER SHARE	EARNINGS PER SHARE Basic earnings per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income (loss) by the weighted average number of common shares after considering the additional dilution related to common stock options and restricted stock. In computing diluted earnings per share, the outstanding common stock options are considered dilutive using the treasury stock method. The Company’s restricted stock awards are treated as outstanding for earnings per share calculations since these shares have full voting rights and are entitled to participate in dividends declared on common shares, if any, and undistributed earnings. As participating securities, the shares of restricted stock are included in the calculation of basic and diluted EPS using the two-class method. For the periods presented, the amount of earnings allocated to the participating securities was not material. The following information is necessary to calculate earnings per share for the periods presented (in thousands, except per-share amounts): Three-Months Ended December 31, Six-Months Ended December 31, 2020 2019 2020 2019 Net income as reported $ 1,228 $ 970 $ 935 $ 1,656 Weighted average common shares outstanding 16,497 16,225 16,444 16,185 Effect of dilutive stock options 432 78 431 51 Weighted average diluted common shares outstanding 16,929 16,303 16,875 16,236 Net income per common share Basic and diluted $ 0.07 $ 0.06 $ 0.06 $ 0.10 Employee stock options excluded from computation of dilutive income per share amounts because their effect would be anti-dilutive — 616 25 645

EQUITY TRANSACTIONS

EQUITY TRANSACTIONS	6 Months Ended
	Dec. 31, 2020
Stockholders' Equity Note [Abstract]
EQUITY TRANSACTIONS	EQUITY TRANSACTIONS During the three and six months ended December 31, 2020 and 2019, respectively, stock options to purchase shares of the Company's common stock were exercised as follows (in thousands except per share amounts): Three-Months Ended December 31, Six-Months Ended December 31, 2020 2019 2020 2019 Options exercised 18,000 10,150 68,531 19,350 Proceeds $ 86 $ 30 $ 311 $ 58 Average exercise price per share $ 4.79 $ 2.96 $ 4.53 $ 3.00 As of December 31, 2020, there was $0.4 million of stock compensation expense related to non-vested awards, which is expected to be recognized over a weighted average period of 2.15 years .

INVENTORY

INVENTORY	6 Months Ended
	Dec. 31, 2020
Inventory Disclosure [Abstract]
INVENTORY	INVENTORY The components of inventory are as follows (in thousands): December 31, 2020 June 30, 2020 Raw materials $ 1,485 $ 1,402 Finished goods 4,838 5,300 Total inventory 6,323 6,702 Less: current portion 5,296 5,638 Inventory, net of current portion $ 1,027 $ 1,064 The current portion of inventory includes amounts which the Company expects to sell in the next twelve month period based on historical sales.

SIGNIFICANT ACCOUNTING POLICI_2

SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Income Taxes	Income Taxes : Deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is established when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The establishment of valuation allowances requires significant judgment and is impacted by various estimates. Both positive and negative evidence, as well as the objectivity and verifiability of that evidence, is considered in determining the appropriateness of recording a valuation allowance on deferred tax assets. The Company has historically recorded a valuation allowance to reduce its deferred tax assets to an amount that is more likely than not to be realized. However, during the year ended June 30, 2020, the Company released the full amount of the valuation
Accounts Receivable	Accounts Receivable: Accounts receivable consist primarily of amounts due to the Company from normal business activities. Accounts receivable balances are determined to be delinquent when the amount is past due based on the contractual terms with the customer. The Company maintains an allowance for doubtful accounts to reflect the likelihood of not collecting certain accounts receivable based on past collection history and specific risks identified among uncollected accounts. Accounts receivable are charged to the allowance for doubtful accounts when the Company determines that the receivable will not be collected and/or when the account has been referred to a third party collection agency. The Company has a history of minimal uncollectible accounts.
Goodwill and Other Identifiable Intangible Assets	Goodwill and Other Identifiable Intangible Assets: Finite-lived intangible assets are amortized over their respective estimated useful lives and evaluated for impairment periodically whenever events or changes in circumstances indicate that their related carrying values may not be fully recoverable. Goodwill is assessed for impairment at least annually. The Company generally performs its annual goodwill impairment analysis using a quantitative approach. The quantitative goodwill impairment test identifies the existence of potential impairment by comparing the fair value of its single reporting unit with its carrying value, including goodwill. If the fair value of a reporting unit exceeds its carrying value, the reporting unit's goodwill is considered not to be impaired. If the carrying value of a reporting unit exceeds its fair value, an impairment charge is recognized in an amount equal to that excess. The impairment charge recognized is limited to the amount of goodwill present in the single reporting unit. These estimates and assumptions could have a significant impact on whether or not an impairment charge is recognized and the amount of any such charge. The Company performs its annual impairment assessment of goodwill during the fourth quarter of each fiscal year.
Recently Issued Accounting Standards	In March 2020, guidance for applying optional expedients and exceptions to ease the potential burden in accounting for reference rate reform on financial reporting was issued. It is elective and applies to all entities, subject to meeting certain criteria, that have contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform on financial reporting. The provisions of the new guidance are effective for interim periods beginning as of March 12, 2020 through December 31, 2022. There has been no material impact on the Company's consolidated financial statements and related disclosures from the modification of its arrangements as of December 31, 2020. The Company will continue to evaluate the standard as well as additional changes, modifications or interpretations which may impact the Company. In June 2016, guidance for credit losses of financial instruments was issued, which requires entities to measure credit losses for financial assets measured at amortized cost based on expected losses rather than incurred losses. The provisions of the new guidance are effective for annual periods beginning after December 15, 2022 (effective July 1, 2023 for the Company), including interim periods within the reporting period, and early application is permitted. The Company is in the initial stages of evaluating the impact of the new guidance on its consolidated financial statements and related disclosures as well as evaluating the available transition methods. The Company will continue to evaluate the standard as well as additional changes, modifications or interpretations which may impact the Company.

SIGNIFICANT ACCOUNTING POLICI_3

SIGNIFICANT ACCOUNTING POLICIES (Tables)	6 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Summary of Revenue by Solution	The components of revenues by solution which reflect a disaggregation of revenue by contract type are as follows (dollar amounts in thousands): Three-Months Ended December 31, 2020 % Total 2019 % Total REVENUES BY SOLUTION: Mailbacks $ 10,452 61.4 % $ 8,564 58.8 % Route-based pickup services 3,491 20.5 % 2,480 17.0 % Unused medications 1,713 10.1 % 2,321 15.9 % Third party treatment services 179 1.1 % 66 0.5 % Other (1) 1,176 6.9 % 1,134 7.8 % Total revenues $ 17,011 100.0 % $ 14,565 100.0 % Six-Months Ended December 31, 2020 % Total 2019 % Total REVENUES BY SOLUTION: Mailbacks $ 16,614 55.2 % $ 15,681 55.7 % Route-based pickup services 6,647 22.0 % 5,137 18.2 % Unused medications 4,074 13.5 % 4,704 16.7 % Third party treatment services 314 1.0 % 85 0.3 % Other (1) 2,513 8.3 % 2,557 9.1 % Total revenues $ 30,162 100.0 % $ 28,164 100.0 % (1) The Company’s other products include IV poles, accessories, containers, asset return boxes and other miscellaneous items with single performance obligations.

LEASES (Tables)

LEASES (Tables)	6 Months Ended
	Dec. 31, 2020
Leases [Abstract]
Summary of Lease Components and Other Information	During the three and six months ended December 31, 2020 and 2019, lease cost amounts, which reflect the fixed rent expense associated with operating leases, are as follows (in thousands): Three-Months Ended December 31, Six-Months Ended December 31, 2020 2019 2020 2019 Lease cost (1) - operating lease cost - fixed rent expense included in: Cost of revenues $ 621 $ 451 $ 1,192 $ 885 Selling, general and administrative 113 79 226 182 Total $ 734 $ 530 $ 1,418 $ 1,067 (1) Finance lease cost, short-term lease cost and variable lease cost were not significant during the period. During the six months ended December 31, 2020 and 2019, the Company had the following cash and non-cash activities associated with leases (in thousands): Six-Months Ended December 31, 2020 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash outflow for operating leases $ 1,357 $ 1,067 Non-cash changes to the Operating ROU Asset and Operating Lease Liability Additions and modifications to ROU asset obtained from new operating lease liabilities $ 1,688 $ 5,126 Additions to ROU asset obtained from operating lease liabilities upon adoption of new guidance $ — $ 4,591
Schedule of Maturities of Operating Lease Liabilities	The future payments due under operating leases as of December 31, 2020 is as follows (in thousands): Future payments due in the twelve months ended December 31, 2021 $ 2,828 2022 2,156 2023 1,945 2024 1,735 2025 1,095 Thereafter 675 Total undiscounted lease payments 10,434 Less effects of discounting (1,024) Lease liability recognized $ 9,410

NOTES PAYABLE AND LONG-TERM D_2

NOTES PAYABLE AND LONG-TERM DEBT (Tables)	6 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Schedule of Long-term Debt	At December 31, 2020 and June 30, 2020, long-term debt consisted of the following (in thousands): December 31, 2020 June 30, 2020 Acquisition loan, monthly payments of $43; maturing March 2022 $ 690 $ 948 Equipment loan, monthly payments of $17; maturing August 2024, net of debt issuance costs of $47 928 929 Real estate loan, monthly payments of $5; maturing August 2024 1,976 1,103 Paycheck Protection Program loan 2,183 2,183 Total long-term debt 5,777 5,163 Less: current portion 2,252 1,658 Long-term debt, net of current portion $ 3,525 $ 3,505
Schedule of Payments Due on Long-term Debt	Payments due on long-term debt subsequent to December 31, 2020 are as follows (in thousands): Twelve Months Ending December 31, 2021 $ 2,252 2022 1,153 2023 272 2024 272 2025 and thereafter 1,875 $ 5,824

STOCK-BASED COMPENSATION (Table

STOCK-BASED COMPENSATION (Tables)	6 Months Ended
	Dec. 31, 2020
Share-based Payment Arrangement [Abstract]
Schedule of Stock-Based Compensation	Total stock-based compensation expense for the three and six months ended December 31, 2020 and 2019 is as follows (in thousands): Three-Months Ended December 31, Six-Months Ended December 31, 2020 2019 2020 2019 Stock-based compensation expense included in: Cost of revenues $ — $ 1 $ — $ 3 Selling, general and administrative 140 120 302 222 Total $ 140 $ 121 $ 302 $ 225

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	6 Months Ended
	Dec. 31, 2020
Earnings Per Share [Abstract]
Schedule of Earnings Per Share	The following information is necessary to calculate earnings per share for the periods presented (in thousands, except per-share amounts): Three-Months Ended December 31, Six-Months Ended December 31, 2020 2019 2020 2019 Net income as reported $ 1,228 $ 970 $ 935 $ 1,656 Weighted average common shares outstanding 16,497 16,225 16,444 16,185 Effect of dilutive stock options 432 78 431 51 Weighted average diluted common shares outstanding 16,929 16,303 16,875 16,236 Net income per common share Basic and diluted $ 0.07 $ 0.06 $ 0.06 $ 0.10 Employee stock options excluded from computation of dilutive income per share amounts because their effect would be anti-dilutive — 616 25 645

EQUITY TRANSACTIONS (Tables)

EQUITY TRANSACTIONS (Tables)	6 Months Ended
	Dec. 31, 2020
Stockholders' Equity Note [Abstract]
Schedule of Stock Option Activity	During the three and six months ended December 31, 2020 and 2019, respectively, stock options to purchase shares of the Company's common stock were exercised as follows (in thousands except per share amounts): Three-Months Ended December 31, Six-Months Ended December 31, 2020 2019 2020 2019 Options exercised 18,000 10,150 68,531 19,350 Proceeds $ 86 $ 30 $ 311 $ 58 Average exercise price per share $ 4.79 $ 2.96 $ 4.53 $ 3.00

INVENTORY (Tables)

INVENTORY (Tables)	6 Months Ended
	Dec. 31, 2020
Inventory Disclosure [Abstract]
Schedule of Inventory	The components of inventory are as follows (in thousands): December 31, 2020 June 30, 2020 Raw materials $ 1,485 $ 1,402 Finished goods 4,838 5,300 Total inventory 6,323 6,702 Less: current portion 5,296 5,638 Inventory, net of current portion $ 1,027 $ 1,064

ORGANIZATION AND BACKGROUND (De

ORGANIZATION AND BACKGROUND (Details)	6 Months Ended
	Dec. 31, 2020state_region
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of route-based pick-up services in state region	32

SIGNIFICANT ACCOUNTING POLICI_4

SIGNIFICANT ACCOUNTING POLICIES - Summary of Revenue by Solution (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Disaggregation of Revenue [Line Items]
Total revenues	$ 17,011	$ 14,565	$ 30,162	$ 28,164
Revenue percentage	100.00%	100.00%	100.00%	100.00%
Mailbacks
Disaggregation of Revenue [Line Items]
Total revenues	$ 10,452	$ 8,564	$ 16,614	$ 15,681
Revenue percentage	61.40%	58.80%	55.20%	55.70%
Route-based pickup services
Disaggregation of Revenue [Line Items]
Total revenues	$ 3,491	$ 2,480	$ 6,647	$ 5,137
Revenue percentage	20.50%	17.00%	22.00%	18.20%
Unused medications
Disaggregation of Revenue [Line Items]
Total revenues	$ 1,713	$ 2,321	$ 4,074	$ 4,704
Revenue percentage	10.10%	15.90%	13.50%	16.70%
Third party treatment services
Disaggregation of Revenue [Line Items]
Total revenues	$ 179	$ 66	$ 314	$ 85
Revenue percentage	1.10%	0.50%	1.00%	0.30%
Other
Disaggregation of Revenue [Line Items]
Total revenues	$ 1,176	$ 1,134	$ 2,513	$ 2,557
Revenue percentage	6.90%	7.80%	8.30%	9.10%

SIGNIFICANT ACCOUNTING POLICI_5

SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Jun. 30, 2020
Accounting Policies [Abstract]
Billings recorded from inventory builds	$ 2,500,000	$ 1,900,000	$ 3,500,000	$ 2,400,000
Solutions sold that were held in vendor managed inventory	$ 4,600,000		$ 4,600,000		$ 2,800,000
Contract with customer, liability, performance obligation, cash consideration exceeds transaction price					2,100,000
Goodwill impairment					$ 0

INCOME TAXES (Details)

INCOME TAXES (Details)	6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Effective income tax rate	24.80%	8.10%
State and local income taxes, percent	5.00%

LEASES - Components of Net Leas

LEASES - Components of Net Lease (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Lessee, Lease, Description [Line Items]
Operating lease cost	$ 734	$ 530	$ 1,418	$ 1,067
Operating cash outflow for operating leases			1,357	1,067
Non-cash changes to the Operating ROU Asset and Operating Lease Liability			$ 1,688	5,126
Weighted average remaining lease term, operating leases	4 years 8 months 8 days		4 years 8 months 8 days
Weighted average discount rate, operating leases	4.40%		4.40%
ASU 2016-02
Lessee, Lease, Description [Line Items]
Non-cash changes to the Operating ROU Asset and Operating Lease Liability			$ 0	4,591
Cost of revenues
Lessee, Lease, Description [Line Items]
Operating lease cost	$ 621	451	1,192	885
Selling, general and administrative
Lessee, Lease, Description [Line Items]
Operating lease cost	$ 113	$ 79	$ 226	$ 182

LEASES - Maturities of Operatin

LEASES - Maturities of Operating Lease Liabilities (Details) - USD ($) $ in Thousands	Jan. 22, 2021	Dec. 31, 2020
Lessee, Operating Lease, Liability, Payment, Due [Abstract]
2021		$ 2,828
2022		2,156
2023		1,945
2024		1,735
2025		1,095
Thereafter		675
Total undiscounted lease payments		10,434
Less interest		(1,024)
Present value of lease liabilities		$ 9,410
Subsequent Event | Pennsylvania | Real estate
Lessee, Lease, Description [Line Items]
Reduction of operating lease, ROU asset	$ 900
Reduction of operating lease liability	900
Lessee, operating lease, liability, to be paid, reduction	$ 1,200

NOTES PAYABLE AND LONG-TERM D_3

NOTES PAYABLE AND LONG-TERM DEBT - Narrative (Details) - USD ($)	Jan. 21, 2021	Apr. 20, 2020	Aug. 21, 2019	Jun. 29, 2018	Dec. 31, 2020	Jan. 22, 2021	Dec. 28, 2020
Letter of Credit
Line of Credit Facility [Line Items]
Amount outstanding					$ 100,000
Credit Agreement
Line of Credit Facility [Line Items]
Maximum borrowing capacity				$ 14,000,000
Percentage of eligible accounts receivable considered for borrowing base				80.00%
Percentage of eligible inventory considered for borrowing base				50.00%
Borrowing base, monetary benchmark				$ 3,000,000
Basis spread of variable rate				50.00%
Interest rate					3.00%
Unused capacity, commitment fee percentage					0.25%
Remaining borrowing capacity					$ 13,900,000
Maximum borrowing capacity, option					17,900,000
Credit Agreement | Working Capital
Line of Credit Facility [Line Items]
Maximum borrowing capacity				$ 6,000,000
Remaining borrowing capacity		$ 6,000,000			5,900,000
Credit Agreement | Business Acquisitions
Line of Credit Facility [Line Items]
Maximum borrowing capacity				$ 8,000,000
Percentage of portion allocated to acquisition purchase price				75.00%
Remaining borrowing capacity		8,000,000			$ 8,000,000
Credit Agreement | Additional Working Capital
Line of Credit Facility [Line Items]
Maximum borrowing capacity				$ 4,000,000
Credit Agreement | Maximum
Line of Credit Facility [Line Items]
Debt cash flow leverage ratio					3
Credit Agreement | Minimum
Line of Credit Facility [Line Items]
Debt service coverage ratio					1.15
Credit Agreement | Term Loan
Line of Credit Facility [Line Items]
Maturity period				5 years
Credit Agreement | Letter of Credit
Line of Credit Facility [Line Items]
Maximum borrowing capacity				$ 2,000,000
Credit Agreement | LIBOR
Line of Credit Facility [Line Items]
Basis spread of variable rate				2.50%
Debt instrument, term of variable rate				1 month
Credit Agreement | LIBOR | Maximum
Line of Credit Facility [Line Items]
Basis spread of variable rate				3.00%
Credit Agreement Amendment
Line of Credit Facility [Line Items]
Maximum borrowing capacity							$ 18,000,000
Loan Agreement
Line of Credit Facility [Line Items]
Maximum borrowing capacity			$ 3,200,000
Interest rate					2.77%
Interest rate at expiration of advancing period					4.15%
Loan Agreement | Real Estate
Line of Credit Facility [Line Items]
Remaining borrowing capacity			2,000,000
Loan Agreement | Equipment
Line of Credit Facility [Line Items]
Remaining borrowing capacity			$ 1,200,000
Loan Agreement | Term Loan
Line of Credit Facility [Line Items]
Maturity period			5 years
Loan Agreement | LIBOR
Line of Credit Facility [Line Items]
Basis spread of variable rate				2.50%
Payment Protection Program loan
Line of Credit Facility [Line Items]
Debt instrument, face amount		$ 2,200,000
Payment Protection Program loan | Term Loan
Line of Credit Facility [Line Items]
Maturity period		2 years
Real Estate Loan Agreement | Subsequent Event
Line of Credit Facility [Line Items]
Maximum borrowing capacity						$ 900,000
Maturity period	5 years
Amortization period	20 years
Interest rate						4.00%
Increase of annual payments for long-term debt						$ 40,000

NOTES PAYABLE AND LONG-TERM D_4

NOTES PAYABLE AND LONG-TERM DEBT - Schedule of Long-term Debt (Details) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2020	Jun. 30, 2020
Debt Instrument [Line Items]
Total long-term debt	$ 5,777	$ 5,163
Less: current portion	2,252	1,658
Long-term debt, net of current portion	3,525	3,505
Term Loan
Debt Instrument [Line Items]
Total long-term debt	5,824
Acquisition loan | Term Loan
Debt Instrument [Line Items]
Monthly payments	43
Total long-term debt	690	948
Equipment loan | Term Loan
Debt Instrument [Line Items]
Monthly payments	17
Debt issuance costs, net	47
Total long-term debt	928	929
Real estate loan | Term Loan
Debt Instrument [Line Items]
Monthly payments	5
Total long-term debt	1,976	1,103
Payment Protection Program loan | Term Loan
Debt Instrument [Line Items]
Total long-term debt	$ 2,183	$ 2,183

NOTES PAYABLE AND LONG-TERM D_5

NOTES PAYABLE AND LONG-TERM DEBT - Schedule of Payments Due on Long-term Debt (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Jun. 30, 2020
Long-term Debt, Fiscal Year Maturity [Abstract]
Total long-term debt	$ 5,777	$ 5,163
Term Loan
Long-term Debt, Fiscal Year Maturity [Abstract]
2021	2,252
2022	1,153
2023	272
2024	272
2025 and thereafter	1,875
Total long-term debt	$ 5,824

STOCK-BASED COMPENSATION (Detai

STOCK-BASED COMPENSATION (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation	$ 140	$ 121	$ 302	$ 225
Cost of revenues
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation	0	1	0	3
Selling, general and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation	$ 140	$ 120	$ 302	$ 222

EARNINGS PER SHARE (Details)

EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Earnings Per Share [Abstract]
Net income as reported	$ 1,228	$ 970	$ 935	$ 1,656
Weighted average common shares outstanding	16,497	16,225	16,444	16,185
Effect of dilutive stock options (in shares)	432	78	431	51
Weighted average diluted common shares outstanding	16,929	16,303	16,875	16,236
Net income per common share
Basic and diluted (in dollars per share)	$ 0.07	$ 0.06	$ 0.06	$ 0.10
Employee stock options excluded from computation of dilutive income per share amounts because their effect would be anti-dilutive (in shares)	0	616	25	645

EQUITY TRANSACTIONS (Details)

EQUITY TRANSACTIONS (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Stockholders' Equity Note [Abstract]
Options exercised (in shares)	18,000,000	10,150	68,531,000	19,350
Proceeds	$ 86	$ 30	$ 311	$ 58
Average exercise price per share (in dollars per share)	$ 4.79	$ 2.96	$ 4.53	$ 3
Compensation expense related to non-vested awards	$ 400		$ 400
Weighted average period			2 years 1 month 24 days

INVENTORY - Schedule of Invento

INVENTORY - Schedule of Inventory (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Jun. 30, 2020
Components of inventory [Abstract]
Raw materials	$ 1,485	$ 1,402
Finished goods	4,838	5,300
Total inventory	6,323	6,702
Less: current portion	5,296	5,638
Inventory, net of current portion	$ 1,027	$ 1,064